Markets:

Overview

News

Currencies

International

Treasuries

Concert Pharmaceuticals, Inc. - Common Stock (NQ:CNCE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 3, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Concert Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 12, 2022

Via Benzinga

58 Stocks Moving In Thursday's Mid-Day Session ↗

May 12, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

Via Benzinga

Concert Pharma: Q1 Earnings Insights ↗

May 05, 2022

Concert Pharma (NASDAQ:CNCE) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

28 Stocks Moving in Thursday's Pre-Market Session ↗

May 12, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 89.7% to $0.1480 in pre-market trading after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...

Via Benzinga

Concert Pharmaceuticals Reports First Quarter 2022 Financial Results

May 05, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Earnings Outlook For Concert Pharmaceuticals ↗

May 04, 2022

Concert Pharmaceuticals (NASDAQ:CNCE) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Concert Pharma Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 29, 2022

Concert Pharma (NASDAQ:CNCE) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Concert Pharma (CNCE) Conference Call Follow this link to...

Via Benzinga

Concert Pharmaceuticals to Report First Quarter 2022 Results on May 5, 2022

April 28, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran ↗

April 25, 2022

Terran Biosciences is slowly but surely finding its place in the psychedelics industry.

Via Benzinga

Concert Pharmaceuticals Earnings Perspective: Return On Capital Employed ↗

March 08, 2022

Benzinga Pro data, Concert Pharmaceuticals (NASDAQ:CNCE) reported Q4 sales of $13.00 thousand. Earnings fell to a loss of $36.13 million, resulting in a 35.43% decrease from last...

Via Benzinga

Recap: Concert Pharmaceuticals Q4 Earnings ↗

March 03, 2022

Concert Pharmaceuticals (NASDAQ:CNCE) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement...

Via Benzinga

A Preview Of Concert Pharmaceuticals's Earnings ↗

March 02, 2022

Concert Pharmaceuticals (NASDAQ:CNCE) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement....

Via Benzinga

Concert Pharmaceuticals to Report Fourth Quarter 2021 Results on March 3, 2022

February 24, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios ↗

February 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...

Via Benzinga

Earnings Scheduled For March 3, 2022 ↗

March 03, 2022

Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...

Via Benzinga

Concert Pharmaceuticals Completes Enrollment in THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

January 04, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharmaceuticals to Present at H.C. Wainwright BIOCONNECT Virtual Conference

January 03, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharmaceuticals to Participate in Fireside Chat at Jefferies London Healthcare Conferences

November 11, 2021

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharmaceuticals, inc (CNCE) Q3 2021 Earnings Call Transcript ↗

November 09, 2021

CNCE earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

How Bad Are Concert Pharmaceuticals's Earnings? | Return On Capital Employed ↗

November 09, 2021

Benzinga Pro data, Concert Pharmaceuticals (NASDAQ:CNCE) reported Q3 sales of $543.00 thousand. Earnings fell to a loss of $26.80 million, resulting in a 530.86% decrease from...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Concert Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update

November 09, 2021

From Concert Pharmaceuticals, Inc.

Via Business Wire

81 Biggest Movers From Yesterday ↗

November 05, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 04, 2021

Gainers Evaxion Biotech (NASDAQ:EVAX) stock moved upwards by 157.5% to $16.74 during Thursday's regular session. Evaxion Biotech's stock is trading at a volume of...

Via Benzinga

55 Stocks Moving In Thursday's Mid-Day Session ↗

November 04, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday. NerdWallet, Inc. (NASDAQ: NRDS) jumped 60% to $28.86 after the...

Via Benzinga

Concert Pharma Stock Surges On $65M Financing From Healthcare Funds ↗

November 04, 2021

Concert Pharmaceuticals Inc (NASDAQ: CNCE) has agreed with BVF Partners L.P. and RA Capital Management to raise gross proceeds of $65 million. In addition,...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 04, 2021

Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million...

Via Benzinga

Concert Pharmaceuticals Announces $65 Million Financing

November 04, 2021

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharmaceuticals to Report Third Quarter 2021 Results on November 9, 2021

November 02, 2021

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharmaceuticals Completes Enrollment in THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

October 25, 2021

From Concert Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.